HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Think beyond the Skin: 2014 Canadian Expert Opinion Paper on Treating to Target in Plaque Psoriasis.

AbstractOBJECTIVE:
Explore the feasibility of Treat to Target in the area of psoriasis as seen in other therapeutic areas such as hypertension, hyperlipidemia, diabetes and rheumatoid arthritis.
METHODS:
Review validated, measurable targets for psoriasis, including physician global assessment (PGA), psoriasis area and severity index (PASI) and dermatology life quality index (DLQI). Examine principles brought forth in the published European consensus on psoriasis and develop a Canadian consensus on Treat to Target in psoriasis.
RESULTS:
As PASI and DLQI are not routinely used in the community setting, we are recommending target at a PGA of zero (clear).
CONCLUSION:
Recommend that the target is a PGA of zero (clear) as it provides a simple and measurable result that the patient and physician can clearly understand.
AuthorsWayne Gulliver, Charles Lynde, Jan P Dutz, Ronald B Vender, Jensen Yeung, Marc Bourcier, Pierre-Luc Dion, Chi-Ho Hong, Gordon Searles, Yves Poulin
JournalJournal of cutaneous medicine and surgery (J Cutan Med Surg) 2015 Jan-Feb Vol. 19 Issue 1 Pg. 22-7 ISSN: 1203-4754 [Print] United States
PMID25775659 (Publication Type: Journal Article)
Copyright© 2014 Canadian Dermatology Association.
Topics
  • Canada
  • Dermatology (methods, standards)
  • Expert Testimony
  • Humans
  • Psoriasis (diagnosis, therapy)
  • Quality of Life
  • Severity of Illness Index

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: